Active — Not RecruitingNot Applicable

Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm

United States10 participantsStarted 2023-09-01

Plain-language summary

The Jacobs Institute is participating in a study designed to collect prospective clinical evidence to evaluate the approved use of the Pipeline™ Flex Embolization Device with Shield Technology™ for the endovascular treatment of adults (22 years of age or older) with wide-necked intracranial aneurysms

Who can participate

Age range22 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults (22 years of age or older) with large or giant wide-necked intracranial aneurysms (IAs) in the internal carotid artery from the petrous to the superior hypophyseal segments. Exclusion Criteria: * Cannot provide consent or legally authorized representative not available to provide consent

What they're measuring

Occurrence of thromboembolic event(s)

Timeframe: 60 days

Trial details

NCT IDNCT06411418

SponsorJacobs institute

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-30

View on ClinicalTrials.gov More Intracranial Aneurysms trials